Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,190,167 papers from all fields of science
Search
Sign In
Create Free Account
BTK gene
Known as:
BRUTON AGAMMAGLOBULINEMIA TYROSINE KINASE
, Bruton tyrosine kinase
, XLA
Expand
This gene is involved in both signaling and B-cell development.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
12 relations
Agammaglobulinaemia tyrosine kinase
BTK protein, human
Cell Differentiation process
Cell Proliferation
Expand
Narrower (1)
BTK wt Allele
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma
Bonnie K. Harrington
,
Heather L. Gardner
,
+16 authors
W. Kisseberth
PLoS ONE
2016
Corpus ID: 16985231
Acalabrutinib (ACP-196) is a second-generation inhibitor of Bruton agammaglobulinemia tyrosine kinase (BTK) with increased target…
Expand
Review
2016
Review
2016
Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia.
K. Maddocks
,
Jeffrey A Jones
Seminars in Oncology
2016
Corpus ID: 26079295
Chronic lymphocytic leukemia (CLL) is the most common adult leukemia and remains incurable outside of the setting of allogeneic…
Expand
2016
2016
A Tec kinase BTK inhibitor ibrutinib promotes maturation and activation of dendritic cells
Gayathri Natarajan
,
S. Oghumu
,
César A. Terrazas
,
S. Varikuti
,
J. Byrd
,
A. Satoskar
Oncoimmunology
2016
Corpus ID: 14065582
ABSTRACT Ibrutinib, a BTK inhibitor, is currently used to treat various hematological malignancies. We evaluated whether…
Expand
Highly Cited
2015
Highly Cited
2015
Selinexor is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia.
Zachary A. Hing
,
Rose Mantel
,
+9 authors
R. Lapalombella
Blood
2015
Corpus ID: 160157
Despite the therapeutic efficacy of ibrutinib in chronic lymphocytic leukemia (CLL), complete responses are infrequent, and…
Expand
2014
2014
Purine derivatives as potent Bruton's tyrosine kinase (BTK) inhibitors for autoimmune diseases.
Q. Shi
,
A. Tebben
,
+18 authors
G. V. De Lucca
Bioorganic & Medicinal Chemistry Letters
2014
Corpus ID: 10125273
2007
2007
Bruton's tyrosine kinase (BTK) is a binding partner for hypoxia induced mitogenic factor (HIMF/FIZZ1) and mediates myeloid cell chemotaxis
Qingning Su
,
Yifu Zhou
,
R. Johns
The FASEB Journal
2007
Corpus ID: 31280345
Hypoxia induced mitogenic factor (HIMF) is a member of the FIZZ/resistin/RELM family of proteins that we have shown to have…
Expand
2001
2001
Phenotypic analysis of conditionally immortalized cells isolated from the BPK model of ARPKD.
W. Sweeney
,
L. Kusner
,
+5 authors
E. Avner
American Journal of Physiology - Cell Physiology
2001
Corpus ID: 26701032
To study the pathophysiology of autosomal recessive polycystic kidney disease (ARPKD), we sought to develop conditionally…
Expand
Highly Cited
1994
Highly Cited
1994
Genomic organization of mouse and human Bruton's agammaglobulinemia tyrosine kinase (Btk) loci.
P. Sideras
,
Susanne Müller
,
+9 authors
Irene Larsson
Journal of Immunology
1994
Corpus ID: 25395964
Btk is a cytoplasmic protein tyrosine kinase (PTK) that has been directly implicated in the pathogenesis of X-linked…
Expand
1994
1994
Isolation of cosmid and cDNA clones in the region surrounding the BTK gene at Xq21.3-q22.
I. Vořechovský
,
D. Vetrie
,
+7 authors
H. Ochs
Genomics
1994
Corpus ID: 24947036
A regional physical and transcription map involving yeast artificial chromosomes (YACs), cosmids, and cDNAs has been constructed…
Expand
1993
1993
Sequence analysis of human T cell lymphotropic virus type I strains from southern India: gene amplification and direct sequencing from whole blood blotted onto filter paper.
V. Nerurkar
,
P. Babu
,
+7 authors
Richard Yanagihara
Journal of General Virology
1993
Corpus ID: 41196463
Human T cell lymphotropic virus type I (HTLV-I) infection in India has been found to be associated with adult T cell leukaemia…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE